| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |